Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06136169 · ClinicalTrials.gov registry record · NA
Reminder-cue Scanning Training for Homonymous Visual Field Loss
A NA study of Homonymous Hemianopia and Homonymous Quadrantanopia, sponsored by Massachusetts Eye and Ear Infirmary.
- Recruiting
- Registry status
- NA
- Development phase
- 30
- Enrollment target
- 1
- Study location
NCT06136169 is a NA study of Homonymous Hemianopia and Homonymous Quadrantanopia that is actively recruiting participants, run by Massachusetts Eye and Ear Infirmary. The registered enrollment target is 30 participants, below the 46-participant average among 3 other Homonymous Hemianopia trials with a reported enrollment target (35% lower). The trial reports 1 study location across 1 state.
The verdict
NCT06136169, a NA study of Homonymous Hemianopia and Homonymous Quadrantanopia, is actively recruiting participants, sponsored by Massachusetts Eye and Ear Infirmary.
- RECRUITING
- Registry status
- NA
- Development phase
- 30 participants
- Enrollment target
- 1
- Study location
Study Summary
This study will evaluate a new approach to training people with visual field loss to scan when driving
Conditions Studied
Interventions
- BEHAVIORAL Reminder-cue scanning training
Study Locations (1)
Massachusetts
- Schepens Eye Research Institute of Mass Eye and Ear - Boston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2024-05-14 |
| Est. Completion | 2026-05 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06136169
The ClinicalTrials.gov registry entry for NCT06136169 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 46-participant average among 3 other Homonymous Hemianopia trials with a reported enrollment target (35% lower). The listed sponsor is Massachusetts Eye and Ear Infirmary, which has 73 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Homonymous Hemianopia appearing as the primary indexed condition, and to 1 intervention - of which Reminder-cue scanning training is the first listed.
NCT06136169 reports 1 study location spanning 1 distinct geographic area - top geographies include Massachusetts.
Frequently Asked Questions
What is clinical trial NCT06136169 about?
NCT06136169 is a clinical study titled "Reminder-cue Scanning Training for Homonymous Visual Field Loss". This study will evaluate a new approach to training people with visual field loss to scan when driving
What is the current status of trial NCT06136169?
This trial is currently recruiting. It is a NA study. The enrollment target is 30 participants. The study started on 2024-05-14. Estimated completion is 2026-05.
What conditions does trial NCT06136169 study?
This clinical trial studies the following conditions: Homonymous Hemianopia, Homonymous Quadrantanopia.
What interventions are being tested in trial NCT06136169?
The interventions under investigation include: Reminder-cue scanning training (BEHAVIORAL).
Who is sponsoring clinical trial NCT06136169?
This trial is sponsored by Massachusetts Eye and Ear Infirmary, which has 73 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06136169 being conducted?
This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Homonymous Hemianopia
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.